Zhao Chen, Luo Qimei, Xia Xi, He Feng, Peng Fenfen, Yu Xueqing, Huang Fengxian
Department of Nephrology, The First Affiliated Hospital, Sun Yat-sen University, Key Laboratory of Nephrology, Ministry of Health of China, Guangdong Provincial Key Laboratory of Nephrology Guangzhou, Guangdong, China.
Eur J Clin Invest. 2014 Nov;44(11):1095-103. doi: 10.1111/eci.12344.
Patients with continuous ambulatory peritoneal dialysis (CAPD) have high all-cause mortality risk that varies extensively among different conditions. The objective of this study was to develop and validate risk models to predict the 2-year all-cause mortality risks of CAPD patients.
A total of 1354 patients who received CAPD treatment > 3 months from a single dialysis centre were enrolled into the study from January 1, 2006 to December 31, 2011 and followed up until June 30, 2013. The dataset was randomly divided into the derivation dataset (2/3, n = 903) and the validation dataset (1/3, n = 451). Baseline information, including demographic characteristics, comorbid conditions and laboratory data, was recorded and included in the models. Risk models were developed using Cox proportional hazards regression. C-statistic, Akaike Information Criterion, Hosmer-Lemeshow χ(2) test and net reclassification improvement (NRI) were performed to evaluate model prediction and validation.
During the entire follow-up period, 175 (19·38%) and 85 (18·85%) patients died in the derivation and validation datasets respectively. A model that included age, diabetes mellitus, hypertension, cardiovascular disease, diastolic blood pressure, serum albumin, serum creatinine, phosphate, haemoglobin and fasting blood glucose demonstrated good discrimination in the derivation and validation datasets to predict 2-year all-cause mortality (C-statistic, 0·790 and 0·759, respectively). In the validation dataset, the above model performed good calibration (χ(2) = 2·08, P = 0·98) and NRI (7·37% compared with model 2, P = 0·05).
The risk model can accurately predict 2-year all-cause mortality in Chinese CAPD patients and external validation is needed in future.
持续性非卧床腹膜透析(CAPD)患者全因死亡风险较高,且在不同情况下差异很大。本研究的目的是开发并验证风险模型,以预测CAPD患者的2年全因死亡风险。
2006年1月1日至2011年12月31日,共有1354例接受CAPD治疗超过3个月的患者从单个透析中心纳入本研究,并随访至2013年6月30日。数据集被随机分为推导数据集(2/3,n = 903)和验证数据集(1/3,n = 451)。记录包括人口统计学特征、合并症和实验室数据在内的基线信息,并纳入模型。使用Cox比例风险回归开发风险模型。进行C统计量、赤池信息准则、Hosmer-Lemeshow χ²检验和净重新分类改善(NRI)以评估模型预测和验证。
在整个随访期间,推导数据集和验证数据集中分别有175例(19.38%)和85例(18.85%)患者死亡。一个包含年龄、糖尿病、高血压、心血管疾病、舒张压、血清白蛋白、血清肌酐、磷酸盐、血红蛋白和空腹血糖的模型在推导数据集和验证数据集中对预测2年全因死亡具有良好的区分度(C统计量分别为0.790和0.759)。在验证数据集中,上述模型具有良好的校准度(χ² = 2.08,P = 0.98)和NRI(与模型2相比为7.37%,P = 0.05)。
该风险模型可以准确预测中国CAPD患者的2年全因死亡风险,未来需要进行外部验证。